Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J De Roo

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Nuclear Medicine|January 1, 1987
Mediastinal parathyroid localization: possible pitfall in technetium-thallium subtraction scintigraphyJ L Coolens, M J De Roo
European Journal of Nuclear Medicine|October 1, 1980
Reflections on the etiology of hot spots on liver scansK K Ang, M J De Roo, P Devos
European Journal of Nuclear Medicine|January 1, 1996
Complexes of technetium-99m with tetrapeptides containing one alanyl and three glycyl moietiesH P Vanbilloen, M J De Roo, A M Verbruggen
European Journal of Nuclear Medicine|June 1, 1993
Technetium-99m labelled human serum albumin for ventriculography: a comparative evaluation of six labelling kitsH P Vanbilloen, K A Verbeke, M J De Roo, et al.
European Journal of Nuclear Medicine|June 1, 1993
Technetium-99m mercaptoalbumin as a potential substitute or technetium-99m labelled red blood cellsK A Verbeke, H P Vanbilloen, M J De Roo, et al.
Nuclear Medicine and Biology|April 1, 1995
Complexes of technetium-99m with tetrapeptides, a new class of 99mTc-labelled agentsH P Vanbilloen, G M Bormans, M J De Roo, et al.
European Journal of Nuclear Medicine|January 1, 1992
Evaluation of the renal excretion characteristics of technetium-99m mercaptoacetylglycyl-D-alanylglycine in healthy volunteersG M Bormans, B J Cleynhen, M J De Roo, et al.
Acta Neurologica Belgica|May 1, 1977
Critical appraisal of angioscintigraphy as a diagnostic procedure in cerebrovascular diseaseG Spincemaille, M J De Roo, P Devos, et al.
European Journal of Nuclear Medicine|September 1, 1993
First experience in healthy volunteers with technetium-99m L,L-ethylenedicysteine, a new renal imaging agentC G Van Nerom, G M Bormans, M J De Roo, et al.
Nuclear Medicine Communications|January 1, 1997
99Tcm-dimercaptopropionyl-HSA prepared from a labelling kit: preliminary investigations as a blood pool agentJ P Cambier, K A Verbeke, H P Vanbilloen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Nuclear Medicine|January 1, 1987
Mediastinal parathyroid localization: possible pitfall in technetium-thallium subtraction scintigraphyJ L Coolens, M J De Roo
European Journal of Nuclear Medicine|October 1, 1980
Reflections on the etiology of hot spots on liver scansK K Ang, M J De Roo, P Devos
European Journal of Nuclear Medicine|January 1, 1996
Complexes of technetium-99m with tetrapeptides containing one alanyl and three glycyl moietiesH P Vanbilloen, M J De Roo, A M Verbruggen
European Journal of Nuclear Medicine|June 1, 1993
Technetium-99m labelled human serum albumin for ventriculography: a comparative evaluation of six labelling kitsH P Vanbilloen, K A Verbeke, M J De Roo, et al.
European Journal of Nuclear Medicine|June 1, 1993
Technetium-99m mercaptoalbumin as a potential substitute or technetium-99m labelled red blood cellsK A Verbeke, H P Vanbilloen, M J De Roo, et al.
Nuclear Medicine and Biology|April 1, 1995
Complexes of technetium-99m with tetrapeptides, a new class of 99mTc-labelled agentsH P Vanbilloen, G M Bormans, M J De Roo, et al.
European Journal of Nuclear Medicine|January 1, 1992
Evaluation of the renal excretion characteristics of technetium-99m mercaptoacetylglycyl-D-alanylglycine in healthy volunteersG M Bormans, B J Cleynhen, M J De Roo, et al.
Acta Neurologica Belgica|May 1, 1977
Critical appraisal of angioscintigraphy as a diagnostic procedure in cerebrovascular diseaseG Spincemaille, M J De Roo, P Devos, et al.
European Journal of Nuclear Medicine|September 1, 1993
First experience in healthy volunteers with technetium-99m L,L-ethylenedicysteine, a new renal imaging agentC G Van Nerom, G M Bormans, M J De Roo, et al.
Nuclear Medicine Communications|January 1, 1997
99Tcm-dimercaptopropionyl-HSA prepared from a labelling kit: preliminary investigations as a blood pool agentJ P Cambier, K A Verbeke, H P Vanbilloen, et al.
Pageof 2